Corrigendum: Efficient in vitro generation of IL-22-secreting ILC3 from CD34+ hematopoietic progenitors in a human mesenchymal stem cell niche

Sabrina B Bennstein; Sandra Weinhold; Özer Degistirici; Robert A J Oostendorp; Katharina Raba; Gesine Kögler; Roland Meisel; Lutz Walter; Markus Uhrberg

doi:10.3389/fimmu.2023.1292209

Corrigendum: Efficient in vitro generation of IL-22-secreting ILC3 from CD34+ hematopoietic progenitors in a human mesenchymal stem cell niche

Front Immunol. 2023 Sep 22:14:1292209. doi: 10.3389/fimmu.2023.1292209. eCollection 2023.

Authors

Sabrina B Bennstein¹, Sandra Weinhold¹, Özer Degistirici², Robert A J Oostendorp³, Katharina Raba¹, Gesine Kögler¹, Roland Meisel², Lutz Walter⁴, Markus Uhrberg¹

Affiliations

¹ Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
² Division of Pediatric Stem Cell Therapy, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Center for Children and Adolescence Health, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
³ Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Internal Medicine III - Hematology and Oncology, Laboratory of Stem Cell Physiology, Munich, Germany.
⁴ Primate Genetics Laboratory, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2021.797432.].

Keywords: CD34 cells+; GMP—Good Manufacturing Practice; ILC3; hematopoietic stem and progenitor cells; innate lymphoid cells (ILCs); mesenchymal stem cells; umbilical cord stem cells (UCSC).

Publication types

Published Erratum